Keywords: Optic nerve; Second cranial nerve; Optic neuropathy; mtDNA; Oxidative phosphorylation; Mitochondrial; Respiratory chain; ADOA; Autosomal dominant optic atrophy; AION; Anterior ischemic optic neuropathy; AROA; Autosomal recessive optic atrophy; ATP; Adenos
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Epidermal growth factor receptor (EGFR); BRAF; Focal adhesion kinase (FAK); Tubulin polymerization; Cancer cell lines; MDR; multidrug resistance; EGFR; epidermal growth factor receptor; EMEA; European Medicines Evaluation Agency; FDA; US Food and Drug Adm
Capillary electrophoresis in the context of drug discovery
Keywords: ACE; affinity capillary electrophoresis; AGP; α-acid glycoprotein; AH; adrenaline hydrochloride; AIμEA; automatic micro-enzyme assay; AL; amlodipine; AT; antithrombin III; Bag3; Bcl2-associated anthanogene 3; BGE; background electrolyte; CM; chylomicron
Keywords: APIs; Active Pharmaceutical Ingredients; AD; applicability domain; ATI; Aquatic Toxicity Index; PBT; Persistence, Bioaccumulation and Toxicity; CAS; Chemical Abstract Service; CCC; concordance correlation coefficient; CEC; Contaminants of Emerging Concern
Keywords: COFRAC; French Accreditation Committee; LC-DAD; liquid chromatography-diode array detector; GC-MS; gas chromatography-mass spectrometry; LC-MS; liquid chromatography-mass spectrometry; HRMS; high resolution mass spectrometry; THC-COOH; 11-Nor-9-ca
Keywords: OA; osteoarthritis; IL; interleukin-1β; TNF; tumor necrosis factor-α; MMPs; metalloproteinases; NO; nitric oxide; FDA; Drug Administration; EMEA; European Medicines Agency; PG; proteoglycans; iNOS; inducible nitric oxide synthase; TEM; transmission elec
Keywords: AAF; analgesics and anti-inflammatory; ABI; antibiotic; AF; assessment factor; AEMPS; Spanish Agency for Medicines and Medical Devices; API; active pharmaceutical ingredient; BBL; β-Blocker; CAS; chemical abstracts service; DDD; defined daily dose; DIU;
Keywords: SUT; single-use technology; CMOs; contract manufacturing organisation(s); mAb; monoclonal antibody; BSL; biosafety level; CIP; cleaning-in-place; SIP; sterilisation-in-place; WFI; water for injection; DSP; downstream processing; CHO; Chinese hamster ovary
Keywords: API; active pharmaceutical ingredient; AUC; area under the curve; BSA; bovine serum albumin; Cmax; peak concentration; COPD; chronic obstructive pulmonary disease; DPI; dry powder inhaler; DPPC; dipalmitoylphosphatidylcholine; ED; emitted dose; EMA; Europ
Phytochemical profiles, phototoxic and antioxidant properties of eleven Hypericum species - A comparative study
Keywords: Hypericum species (Clusiaceae Lindl.); Phototoxicity; Polyphenols; Hypericin; Hyperforin; Antioxidants; SJW; St. John's wort; EMEA; European Medicine Agency; WHO; World Health Organization; PTFE; Polytetrafluoroethylene; DPPH; di(phenyl)-(2,4,6-trinitroph
A new cause of false positive voriconazole levels: Watch your collection tubes!
Keywords: TDM; Therapeutic drug monitoring; VOR; Voriconazole; HPLC-UV; High-performance liquid chromatography with ultraviolet detector; FDA; Food and drug administration; EMEA; European Medicines Agency; PRE; Percentage relative error; LLOQ; Lower limit of quanti
PerspectivePatients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards
Keywords: Alzheimer's; Dementia; Ethics; Clinical trial; IRB; FDA; EMEA; Therapeutic; Intervention; Prevention; Treatment;
PBT assessment and prioritization of contaminants of emerging concern: Pharmaceuticals
Keywords: AD; Applicability Domain; API; Active Pharmaceutical Ingredient; B; Bioaccumulative; BCF; BioConcentration Factor; bor AD; borderline Applicability Domain; CAS; Chemicals Abstracts Service; CEC; Contaminants of Emerging Concern; EMEA; European Medicines A
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use
Keywords: 1,4-BD; 1,4-butanediol; AM; ante mortem; AMCD; Advisory Council on the Misuse of Drugs; BNF; British National Formulary; BZP; benzylpiperazine; Carboxy-THC; 11-nor-9-carboxy-delta-9-THC; CNS; central nervous system; CPP; 1-(3-chlorophenyl)piperazine hydro
Isotrétinoïne et grossesse : bilan français de 25 années de suivi
Keywords: isotrétinoïne; grossesse; isotretinoïn; pregnancy; Afssaps; Agence française de sécurité sanitaire des produits de santé; AMM; autorisation de mise sur le marché; ANSM; Agence nationale de sécurité du médicament et des produits de santé; CRAT;
Workshop ReportEvaluation of the Threshold of Toxicological Concern (TTC) - Challenges and approaches
Keywords: BMD; Benchmark Dose; Cefic; European Chemical Industry Council; COC; cohort of concern; CPDB; Carcinogen Potency Database; DSSTox; EPA's Distributed Structure-Searchable Toxicity Database Network; EFSA; European Food Safety Authority; EMEA; European Med
Heteronuclear NMR provides an accurate assessment of therapeutic insulin's quality
Keywords: SOFAST; band-selective optimized-flip-angle short-transient; HMQC; heteronuclear multiple quantum coherence; HSQC; heteronuclear single quantum correlation; EMEA; European Medicine Agency; SOFAST NMR; Insulin; Lispro; Biodrug; Biosimilar;
Actualización detallada de las guÃas de la ESC para el manejo de la fibrilación auricular de 2012
Keywords: Fibrilación auricular; Sociedad Europea de CardiologÃa; GuÃas; Anticoagulación; Nuevos anticoagulantes orales; Cierre de la orejuela izquierda; Control de la frecuencia cardiaca; Cardioversión; Control del ritmo cardiaco; Fármacos antiarrÃtmicos; T
Emerging diabetes therapies and technologies
Keywords: CSII; continuous subcutaneous insulin infusion; CGM; continuous glucose monitoring; DKA; diabetic ketoacidosis; DPP-IV; dipeptidyl peptidase-IV; EMEA; European Medicines Agency; FDA; Food and Drug Administration; FCL; fully closed-loop; GRAS; generally re
Devil's Claw-A review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens
Keywords: 5-LOX; 5-lipo-oxygenase; 6â²-PCHG; 6â²-O-p-coumaroylharpagide; 8-PCHG; 8-p-coumaroylharpagide; BCL; Bicuculline; COX-2; cyclooxygenase-2; CREB; cAMP response element-binding; CYP; cytochrome P450; DAD; diode array detection; DPPH; 2, 2-diphenyl-1-picryl
Refined analysis of antigen-specific antibody responses - A new one-step tool in immunogenicity studies
Keywords: APC; antigen presenting cells; BSA; bovine serum albumin; CI; confidence interval; CV%; coefficient of variation %; ELISA; enzyme linked immunosorbent assay; EMEA; European medicines agency; FDA; food and drug administration; FI; fluorescence intensity; H
Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
Keywords: AE; adverse event; CBC; complete blood count; CDC; centers for Disease Control and Prevention; CHMP; Committee for Human Medicinal Products; CI; confidence interval; DSJI; disposable-syringe jet injection/injector; EMEA; European Medicines Agency; FDA; U.
Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability
Keywords: SMID; severe motor and intellectual disability; EMEA; European Medicines Evaluation Agency; FDA; Food and Drug Administration; GMTR; geometric mean titer ratio; HAI; hemagglutination-inhibition; Disabled person; H1N1; Immunogenicity; Influenza A; Influenz
The use of atomic spectroscopy in the pharmaceutical industry for the determination of trace elements in pharmaceuticals
Keywords: Atomic spectroscopy; Pharmaceuticals; Elements; USP; EMEA
Perfil clÃnico y curso evolutivo de los pacientes tratados con efalizumab tras la suspensión de su autorización por la EMEA. Estudio observacional y multicéntrico
Keywords: Efalizumab; EMEA; Rebote; Exacerbación inflamatoria generalizada; Efalizumab; European Medicines Agency; Rebound; Generalized inflammatory flare;
Influenza vaccine for pregnant women in resource-constrained countries: A review of the evidence to inform policy decisions
Keywords: ACIP; US Advisory Committee on Immunization Practices; ALRI; acute lower respiratory infections; EMEA; European Medicines Agency; FDA; US Food and Drug Administration; GACVS; WHO Global Advisory Committee on Vaccine Safety; HAI; serum hemagglutination inh
Stem cell cultivation in bioreactors
Keywords: 2D; Two-Dimensional; 3D; Three-Dimensional; BFU-E; Burst-Forming Units-Erythrocyte; CFCs; Colony-Forming Cells; CFU-F; Colony-Forming Units-Fibroblast; CFU-GEMM; Colony-Forming Units-Granulocyte-Erythrocyte-Macrophage-Megakaryocyte; CFU-GM; Colony-Forming
ReviewSafety of botanical ingredients in personal care products/cosmetics
Keywords: CA; comparative approach; CG; congeneric group(s); CIR; Cosmetic Ingredient Review; COLIPA; European Cosmetics Manufacturers Association; CS; complex substances; DST; Dermal Sensitisation Threshold; EFSA; European Food Safety Authority; EMEA; European Med
ESC/EAS Guidelines for the management of dyslipidaemias
Keywords: 4D Die; Deutsche Diabetes Dialyse Studie; 4S; Scandinavian Simvastatin Survival Study; ABC-1; ATP-binding cassette transporter 1; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ACS; acute coronary syndrome; AIM-HIGH; Atherothrombosis Intervent
Therapeutic indications in oncology: Emerging features and regulatory dynamics
Keywords: Therapeutic indication; EMEA; Restriction of indication; Regulatory; Anticancer drugs; Extension of indication; Oncology
Research ArticleShortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis
Keywords: ALT; alanine aminotransferase; EMEA; European Medical Association; HCV; hepatitis C virus; NTT; number needed to treat; PEG-IFN; pegylated interferon; RCT; randomized controlled trial; RVR; rapid virological response; SVR; sustained virological response;
Clinical development of drugs for epilepsy: A review of approaches in the United States and Europe
Keywords: Epilepsy; Seizure; Antiepileptic drug; Anti-seizure drug; Drug development; FDA; EMEA; Regulation; Drug registration
Recommandations pour le diagnostic et la prise en charge de la rhinite allergique (épidémiologie et physiopathologie exclues) - Texte long
Keywords: AINS; Anti-Inflammatoire Non Stéroïdien; ARIA; Allergic Rhinitis and its Impact on Asthma; DNS; Dysfonctionnement Naso-Sinusien; EFR; Ãpreuves Fonctionnelles Respiratoires; EMEA; European Medicines Evaluation Agency (Agence Européenne d'Evaluation d
Recommandations pour le diagnostic et la prise en charge de la rhinite allergique (épidémiologie et physiopathologie exclues) - Texte long
Keywords: AINS; Anti-Inflammatoire Non Stéroïdien; ARIA; Allergic Rhinitis and its Impact on Asthma; DNS; Dysfonctionnement Naso-Sinusien; EFR; Ãpreuves Fonctionnelles Respiratoires; EMEA; European Medicines Evaluation Agency (Agence Européenne d'Evaluation d
Manejo de la hipertensión arterial en niños y adolescentes: recomendaciones de la Sociedad Europea de Hipertensión
Keywords: Niños; Adolescentes; Sociedad Europea de hipertensión; Hipertensión arterial; Recomendaciones; AAP; Academia Americana de PediatrÃa; alloTHF; alotetrahidrocortisol; ARA; antagonista del receptor de la angiotensina; ASD; angiografÃa por sustracción d
Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants
Keywords: European Medicines Agency; EMEA; Committee for Medicinal Products for Human Use; CHMP; Antidepressants; Major depression; Drug evaluation
ReviewEthics in clinical research
Keywords: RCT; randomized clinical trial; EMEA; European Medicines Agency; EU; European Union; DMARD; disease modifying anti-rheumatic drugs; Hb A1c; glycosylated hemoglobin; FDA; Food and Drug Administration; HDL; high-density lipoprotein; SSRI; selective serotoni
L'Europe des médicaments : modalités d'enregistrement et cas particulier des antibiotiques
Keywords: Procédures d'enregistrement; Autorisation de mise sur le marché; Antibiotiques; EMEA; Afssaps; Registration procedures; Marketing authorisation; Antibacterial agents; EMEA; AFSSAPS;
Guidelines for the Management of Mucopolysaccharidosis Type I
Keywords: ADLs; Activities of daily living; ATR; Abdominal thorax rebalance; BAEP; Brain stem auditory evoked potential; BHM; Bronchial hygiene maneuvers; BMT; Bone marrow transplant; CFP; Federal Psychology Council; CH; Communicating hydrocephalus; CHF; Congestive
Medicines for Children: A Matter of Taste
Keywords: EMEA; European Medicines Agency; VAS; Visual analogue scale;
How bacteraemia is reviewed by medicines licensing authorities in Europe
Keywords: Bacteraemia; Daptomycin; Linezolid; Quinupristin/dalfopristin; Tigecycline; EMEA
Reducción de la frecuencia cardiaca. Otras oportunidades terapéuticas
Keywords: Frecuencia cardiaca; Riesgo cardiovascular; Isquemia miocárdica; Insuficiencia cardiaca; Canales If; Ivabradina; Heart rate; Cardiovascular risk; Myocardial ischemia; Heart failure; If channels; Ivabradine; AV; aurÃculo-ventricular; BEAUTIFUL; evaluatio
From laboratory to Phase I/II cancer trials with recombinant biotherapeutics
Keywords: Antibody; GMP; Fermentation; Pichia pastoris; Pre-clinical; Phase I/II; ADEPT; EMEA; EU Directive
Tissue Engineering for the Lower Urinary Tract: A Review of a State of the Art Approach
Keywords: Animal and clinical trials; Bladder; CAT; EMEA; Legal; Nerve; Reconstructive urology; Stem cells; Tissue engineering; Urethra; Urinary sphincter
Non-clinical development of cancer vaccines: Regulatory considerations
Keywords: Toxicology; Animal model; Regulatory affairs; Biotechnology; Tumour; Anti-idiotypic; DNA vaccines; Monoclonal antibodies; EMEA; FDA
Differences in product information of biopharmaceuticals in the EU and the USA: implications for product development
Keywords: Biopharmaceuticals; Regulation; EMEA; FDA; Marketing authorisation; Product information; Labelling;
Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003
Keywords: drug authorization; EMEA; health-related quality of life; patient perspective; patient-reported outcome; regulatory issues;